New antibiotics for skin infections get seal of approval from European Medicines Agency Three new antibiotics to treat serious skin infections have been recommended for approval by the European Medicines Agency.…
Anti-VEGF therapies could have role in treating TB Bevacizumab, an anti-VEGF drug, was able to normalise granuloma vasculature, improve the delivery of small molecules and decrease hypoxia in a rabbit model of tuberculosis.…
Study shows how glucocorticoids tightly control the inflammatory response IRAK-M, a key negative regulator of inflammatory pathways, may represent a new therapeutic target to suppress bacteria-induced inflammation, say researchers.…
Finding patient zero Advances in molecular techniques make it easier to track down the first patient to be infected with a disease while it is still useful.…
How Vibrio cholera has adapted to its environmentA recent study published in Science describes the mechanism by which the cholera bacterium propagates.…
Whooping cough vaccines could lose their effectivenessScientists are warning that current whooping cough vaccines may not be able to control the disease in future.…
Bacteria’s protein machinery may offer antibiotic target Researchers have unveiled a snapshot of the molecular machinery that bacteria use to build polysaccharide chains that protect them from immune attack.…
2014: The Pharmaceutical Journal’s news in review Looking back at some of the biggest news stories from the past year. …
Paper towels versus hot air hand dryers — which is more hygienic? Despite the myth that hot air dryers are more hygienic, Andrew Haynes explains that paper towels are actually better for three important reasons.…
Antimicrobial resistance will lead to an additional 10 million deaths each year worldwide by 2050 Failure to address growing resistance to antibiotics and other drugs will result in the deaths of an additional 10 million people each year worldwide by 2050 and cost the global economy up to US$100tn, projects a UK report.…